sun pharma stock daily chart analysis
Sun pharma stock on last trading session closed at 628 with gain. On daily chart, Sun pharma stock price, trend and momentum both are bullish and stock slowly inching upside.
For short-term traders above 590, trading will remain buy on dips. On upside 650 and then 682 are target zones for March series. On downside, 590 and 562 are strong support. Daily chart indicators are in bullish territory reflecting underlying strong demand.
sun pharma stock weekly chart analysis
Sun pharma stock this week showing gains and this will be fourth gaining week for this stock. From medium to long term view, Sun pharma stock will be buy and heading towards its targets of 680 and then possibly 790 in upcoming weeks. On downside 565 is major average zone and above it, medium term strategy for Sun pharma stock remain buy on dips. Below that, 460 will be next support zone. In upcoming time, expect much more upside for this stock as fundamentals as well as technical trend both are in favor of buying.
sun pharma stock monthly chart analysis
Sun pharma stock is outperformer of the market and had given almost 25% returns to investors. on monthly chart also stock price trend and momentum is strong bullish and expect higher levels in upcoming months here. Above 520 on monthly closing basis, any major correction will be buying and accumulation opportunity. On upside 12-month targets is 730 rupees while 24-36 months target level will be 940 rupee. Below 520 next major and historic support will be around 330-350 zone.
sun pharma company description
Sun Pharmaceutical Industries Limited is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: US Generics, Indian Branded Generics, International Branded Generics (Rest of the world, except the US and India) and Active Pharmaceutical Ingredients (API). Its brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. It makes specialty APIs, including peptides, steroids, hormones and anticancers. The Company manufactures 170 APIs. It’s API products include Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol.
sun pharma stock fundamental ratios
|Range||628.85 – 647.90|
|52 week||392.82 – 651.90|